Profund Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-16,437
| Closed | -$320K | – | 1548 |
|
|
2018
Q1 | $320K | Buy |
16,437
+2,302
| +16% | +$45.2K | 0.01% | 1094 |
|
|
2017
Q4 | $235K | Sell |
14,135
-2,839
| -17% | -$52K | 0.01% | 1279 |
|
|
2017
Q3 | $345K | Buy |
16,974
+2,259
| +15% | +$43.2K | 0.01% | 1008 |
|
|
2017
Q2 | $237K | Sell |
14,715
-4,499
| -23% | -$66.5K | 0.01% | 1259 |
|
|
2017
Q1 | $243K | Sell |
19,214
-6,500
| -25% | -$78.5K | 0.01% | 1278 |
|
|
2016
Q4 | $341K | Buy |
25,714
+10,445
| +68% | +$179K | 0.02% | 1146 |
|
|
2016
Q3 | $362K | Buy |
15,269
+2,430
| +19% | +$65.3K | 0.02% | 977 |
|
|
2016
Q2 | $370K | Sell |
12,839
-683
| -5% | -$22.3K | 0.02% | 985 |
|
|
2016
Q1 | $433K | Sell |
13,522
-3,823
| -22% | -$134K | 0.02% | 847 |
|
|
2015
Q4 | $742K | Buy |
17,345
+1,225
| +8% | +$48.9K | 0.04% | 487 |
|
|
2015
Q3 | $568K | Sell |
16,120
-7,360
| -31% | -$332K | 0.03% | 488 |
|
|
2015
Q2 | $1.08M | Sell |
23,480
-4,772
| -17% | -$226K | 0.04% | 377 |
|
|
2015
Q1 | $1.32M | Buy |
28,252
+9,644
| +52% | +$384K | 0.05% | 346 |
|
|
2014
Q4 | $590K | Buy |
18,608
+5,164
| +38% | +$151K | 0.02% | 723 |
|
|
2014
Q3 | $319K | Sell |
13,444
-3,898
| -22% | -$99.9K | 0.01% | 968 |
|
|
2014
Q2 | $520K | Sell |
17,342
-2,108
| -11% | -$56.9K | 0.02% | 880 |
|
|
2014
Q1 | $514K | Sell |
19,450
-21,732
| -53% | -$543K | 0.02% | 857 |
|
|
2013
Q4 | $1.03M | Buy |
41,182
+21,196
| +106% | +$473K | 0.05% | 497 |
|
|
2013
Q3 | $410K | Buy |
19,986
+2,952
| +17% | +$61K | 0.02% | 1077 |
|
|
2013
Q2 | $340K | Buy |
+17,034
| New | +$302K | 0.02% | 880 |
|
Profund Advisors's IPXL Position: Q2 2018 in Review
Profund Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 16,437 shares — an estimated $320K sold.
Profund Advisors first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $1.32M in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Profund Advisors reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Profund Advisors sold 16,437 Impax Laboratories, Inc. shares in Q2 2018, an estimated $320K.
- Profund Advisors first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Profund Advisors's Impax Laboratories, Inc. position peaked at $1.32M in Q1 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Profund Advisors's 13F filing for Q2 2018, filed 13 Aug 2018.